Posts Tagged ‘Moderna’
Ebola update: Moderna moves on rare-strain vaccine as Rhode Island monitors select travelers
Ebola update: Moderna is advancing work on a potential vaccine for a rare strain with no licensed vaccine, while Rhode Island has activated traveler monitoring and U.S. airport screening continues.
Read MoreFDA approves new Pfizer, Moderna vaccines as COVID wave increases – Nick Landekic
by Nick Landekic, contributing The U.S. Food and Drug Administration on Thursday approved the latest reformulated COVID vaccines, making it possible for people over 6 months of age to get additional protection in the midst of the ongoing and still increasing surge this summer of the virus. What you need to know: We are now…
Read MoreNew updated COVID-19 Boosters now available in Rhode Island
Updated COVID-19 Booster Doses to be Available in Rhode Island Bivalent boosters to target two strains of COVID-19 With a new, more comprehensive COVID-19 booster dose now authorized and recommended by federal health officials, these updated booster shots will start to become available in Rhode Island this week and next. “This is a good reminder…
Read MoreModerna and Pfizer COVID vaccine for children 6 months+ gets FDA approval
Today, the U.S. Food and Drug Administration authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include use in children down to 6 months of age. CVS has announced it will provide vaccines for children 18 months and older – otherwise parents can access their…
Read MoreNEW: Moderna announces new booster that is Omicron variant specific
Moderna announces new booster that is Omicron variant specific Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing mRNA-1273 (Spikevax) and a vaccine candidate targeting the Omicron variant of concern. A 50 µg booster dose of mRNA-1273.214 met…
Read MoreMoving ahead with COVID vaccines for young children
Moderna (6 mos-5 yrs) and Pfizer (5-11 yrs booster) are next up seeking approval as vaccines. The Moderna will be 2 shots, 4 weeks apart, at 25% strength of an adult shot for children 6 mos to 5 years. Pfizer’s approval request is for a booster for children 5 to 11. After the age of…
Read MoreModerna COVID vaccine should be coming soon for children 6 months to 6 years
Moderna, Inc. announced Wednesday that positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 vaccine in children 6 months to under 2 years and 2 years to under 6 years of age. This interim analysis showed a robust neutralizing antibody response in both age groups after a 25 µg two-dose primary…
Read MoreModerna joins Pfizer in recommending 4th vaccine, but expands to all adults, 18+
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted a request to the U.S. Food and Drug Administration (FDA) for an amendment to the emergency use authorization (EUA) to allow for a fourth dose of its COVID-19 vaccine (mRNA-1273) in adults 18 years of age and…
Read MoreModerna, Johnson & Johnson Boosters available now – Mix & Match OK
Moderna, Johnson & Johnson COVID-19 Vaccine Boosters Now Available; Recommendations Allow Individuals to Choose Type of Vaccine for Booster Dose Governor Dan McKee and the Rhode Island Department of Health announced today that Moderna and Johnson & Johnson (Janssen) COVID-19 vaccine boosters are now available and recommended as follows: Moderna A single booster dose of…
Read MoreNEW: CDC recommends immunocompromised get additional vaccine 28 days after 2nd vaccine
COVID-19 Vaccines for Moderately to Severely Immunocompromised People What You Need to Know People with moderately to severely compromised immune systems are especially vulnerable to COVID-19, and may not build the same level of immunity to 2-dose vaccine series compared to people who are not immunocompromised. CDC recommends that people with moderately to severely compromised…
Read More